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Object. Reported rates of CSF shunt infection vary widely across studies. The study objective was to determine the 
CSF shunt infection rates after initial shunt placement at multiple US pediatric hospitals. The authors hypothesized that 
infection rates between hospitals would vary widely even after adjustment for patient, hospital, and surgeon factors.
Methods. This retrospective cohort study included children 0-18 years of age with uncomplicated initial CSF 
shunt placement performed between January 1, 2001, and December 31, 2005, and recorded in the Pediatric Health 
Information System (PHIS) longitudinal administrative database from 41 children’s hospitals. For each child with 24 
months of follow-up, subsequent CSF shunt infections and procedures were determined.
Results. The PHIS database included 7071 children with uncomplicated initial CSF shunt placement during this 
time period. During the 24 months of follow-up, these patients had a total of 825 shunt infections and 4434 subse­
quent shunt procedures. Overall unadjusted 24-month CSF shunt infection rates were 11.7% per patient and 7.2% per 
procedure. Unadjusted 24-month cumulative incidence rates for each hospital ranged from 4.1 to 20.5% per patient 
and 2.5-12.3% per procedure. Factors significantly associated with infection (p < 0.05) included young age, female 
sex, African-American race, public insurance, etiology of intraventricular hemorrhage, respiratory complex chronic 
condition, subsequent revision procedures, hospital volume, and surgeon case volume. Malignant lesions and trauma 
as etiologies were protective. Infection rates for each hospital adjusted for these factors decreased to 8.8-12.8% per 
patient and 1.4—5.3% per procedure.
Conclusions. Infections developed in > 11 % of children who underwent uncomplicated initial CSF shunt place­
ments within 24 months. Patient, hospital, and surgeon factors contributed somewhat to the wide variation in CSF shunt 
infection rates across hospitals. Additional factors may contribute to variation in CSF shunt infection rates between 
centers, but further study is needed. Benchmarking and future prospective multicenter studies of CSF shunt infection 
will need to incorporate these and other patient, hospital, and surgeon factors. (DOI: 103171/20093.PEDS08215)
Key Words • cerebrospinal fluid hydrocephalus • neurosurgery • 
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Abbreviations used in this paper: CCC = complex chronic condi­
tion; 1CD-9-CM = International Classification of Diseases, Ninth 
Revision, Clinical Modification; 1VH = intraventricular hemor­
rhage; PHIS = Pediatric Health Information System.
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ences in study design account for some variation between 
studies, variation in infection rates may also be the result 
of patient, hospital, and/or surgeon factors. Patient factors 
considered in association with CSF shunt infection include 
chronological age,5-8-12-13-21,26-30-33-35-37'42 gestational age,8-11-29-30 
postconceptional age,27 sex,11 26273037 birth weight,811 
weight at surgery,27 indication for shunt placement includ­
ing myelomeningocele and IVH,11’12’2730 33’36’373942 comor­
bidities,122737 and length of hospital stay prior to shunt 
placement.27 The results of the few multicenter studies of 
CSF shunt infection conducted suggest that hospital factors 
(hospital and its case volume9) and surgeon factors (includ­
ing surgeon, experience, and his/her case volume,59103245 
and the time of year25 as a reflection of resident surgeon 
experience) also contribute to CSF shunt infection.
The goal of this study was to better understand varia­
tions in CSF shunt infection rates between hospitals af­
ter applying a consistent definition of CSF shunt infec­
tion in a database containing administrative and clinical 
data from 41 children’s hospitals. The specific objectives 
were to 1) determine CSF shunt infection rates after ini­
tial shunt placement at multiple pediatric hospitals; 2) de­
termine patient, hospital, and surgeon factors associated 
with shunt infection; and 3) determine shunt infection 
rates after adjustments for significant patient, hospital, 
and surgeon factors. We hypothesized that infection rates
ment for patient, hospital, and surgeon factors, meaning 
that some, but not all, of the variation seen between hos­
pitals is attributable to those factors.
Methods
Study Design and Data Source
We conducted a retrospective cohort study using the 
PHIS database. The PHIS database was developed by the 
Child Health Corporation of America and contains ad­
ministrative and limited clinical data on all discharges 
from member hospitals (41 not-for-profit free-standing 
children’s hospitals in the US). The data warehouse func­
tion for the database is managed by Thomson Reuters, 
and data are subjected to several reliability and validity 
checks before incorporation into the database. Patients 
can be identified using consistently encrypted medical 
record numbers, allowing cross-linking of encounters 
over time. The study was reviewed and exempted from 
annual review by the Institutional Review Boards at the 
University of Utah and Children’s Hospital and Regional 
Medical Center.
Study Population
Children 0-18 years of ages who underwent initial 
CSF shunt placement with a discharge date between Janu­
ary 1,2001, and December 31,2005, were identified from 
all hospitals in PHIS. To identify children who underwent 
initial CSF shunt placement, we used an iterative query 
based on ICD-9-CM procedure and diagnosis codes (Fig.
1). This query uses primarily procedure codes so as to 
overcome the limitation of less specific diagnosis coding 
in administrative databases such as the PHIS. The query
is designed to obtain uncomplicated initial CSF shunt 
placements, eliminating children who may have been in­
fected elsewhere from the comparison of infection rates 
between centers. After the initial analysis suggested that 
88% of CSF shunt infections developed within 24 months 
of the initial CSF shunt placement, we limited the study 
population to children with 24 months of follow-up (7071 
children).
Outcome Variables
The primary outcome variable was a subsequent ad­
mission with the ICD-9-CM discharge diagnosis code for 
shunt infection (996.63) through December 31, 2006. We 
conducted an independent chart review at a single institu­
tion, confirming that 92% (11 of 12) of that institution’s 
CSF shunt infection admissions met National Nosocomi­
al Infection Surveillance criteria for CSF shunt infection.1 
A secondary outcome variable was subsequent CSF shunt 
revision(s). Each patient’s shunt revision procedures were 
identified by subsequent admissions with the ICD-9-CM 
discharge procedure codes for shunt removal (02.43) 
and shunt placement (02.3), or shunt replacement (02.42, 
54.95), or the ICD-9-CM discharge diagnosis code for 
shunt malfunction (996.2).
Predictor Variable and Covariates
The main predictor variable of CSF shunt infection 
rate was hospital. Covariates available in the PHIS data­
base include those patient, hospital, and surgeon factors 
shown in Table 1. Patient age was categorized a priori in 
groups relevant to the diagnosis and management of hy­
drocephalus. Race/ethnicity was categorized into 5 mutu­
ally exclusive designations (non-Latino white, non-Latino 
black, Latino, Asian, and Other). Payer was categorized 
by public (Medicare, Medicaid, Title V, other government 
payer), private (Blue Cross, other insurance company, 
HMO), or other (self pay, no charge). Indication for shunt 
placement was determined after review of the ICD-9-CM 
diagnosis codes that occurred at a frequency of > 1% of
assigned etiology at the time of initial shunt placement 
with the concurrent assignment of the following diagno­
sis codes: TVH (772.lx), myelomeningocele (653.7, 655.0, 
741.x), CNS tumor (191-194, 198.3-198.4, 225.0-2 and 
225.8-9,237.0-1 and 237.5-7,239.6), meningitis (320-322, 
326), and trauma (767.4, 851.xx-854.xx, 995.55). The in­
dications were neither mutually exclusive nor did they de­
scribe the entire population. Comorbidities were grouped 
into CCC, an ICD-9-CM diagnosis code-based system of 
classifying pediatric conditions associated with morbidity 
and mortality.1516 We redefined the neuromuscular and ma­
lignancy categories to exclude indications for CSF shunts 
as previously described.41 Distal shunt location was cat­
egorized by the assignment of any ICD-9-CM procedure 
code into ventriculoperitoneal (02.34) and other (any other 
02.3x). Case mix severity, based on a patient’s All-Patient 
Refined Diagnosis-Related Group (version 20, 3 M-Corp) 
and severity level, reflects both patient and hospitalization 
complexity. Categorization of hospital volume was done 
a priori, and surgeon volume was done after examination
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Fig. 1. Flow chart showing the PHIS database study cohort after excluding children with external ventricular drain placement 
only, complicated initial shunts, and previous CSF shunts.
of univariate distribution. We also considered the patient’s 
CSF shunt revision procedures (categorized into none, 1, 
and > 2) subsequent to initial placement but prior to first 
CSF shunt infection as a risk factor for infection.
Statistical Analyses
We first performed univariate analysis to describe our
tion of patients in whom CSF shunt infections developed 
within 24 months after the initial CSF shunt placement at 
each PFIIS hospital (that is, the cumulative incidence rates 
of CSF shunt infection aggregated by hospital). Because 
there was a > 60-fold difference between hospitals in the 
number of patients included, we report infection rates for 
the hospitals with adequate volume. In Fig. 2 we provide 
unadjusted 24-month infection rates for hospitals with at
(there were 37 hospitals with > 50 initial shunt placements 
and 39 hospitals with > 50 total shunt procedures).
Next we examined the association of patient, hospital, 
and surgeon factors with CSF shunt infection in bivariate
analysis using chi-square tests (Table 2). We then used genr 
eralized linear models to generate adjusted rates of CSF 
shunt infection per patient (rates per hospital adjusted for 
significant patient, surgeon, and hospital factors) and per 
procedure. Generalized linear modeling allows regres­
sion of Poisson distributed data, such as cumulative rates, 
after transformation by a link function (log link function 
for Poisson models). Again we report adjusted 24-month 
infection rates for hospitals with adequate volume (Fig. 3). 
Per patient rates were adjusted for hospital, sex, race/eth­
nicity, payer, and numbers of revisions; per procedure rates 
were adjusted for hospital, age, sex, race/ethnicity, IVH, 
CNS tumor, meningitis etiologies, the presence of cardio­
vascular, respiratory, and congenital CCCs, length of stay, 
shunt type, and case mix index. . . .
odds (Table 3). Significant predictors of CSF shunt infec­
tion (p < 0.10) were evaluated in a multivariable analysis. 
Generalized estimating equations were used for multivar­
iable analysis to allow for a hierarchical structure (mix­
ture of hospital-level and surgeon-level) covariates.44
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TABLE 1: Summary of characteristics of the 7071-patient study 
population*
TABLE 1: Summary of characteristics of the 7071-patient study
*
Characteristic No. of Patients (%)
age
<30 days 2009 (28.4)
1-6 mos 1736 (24.6)
6-48 mos 1823 (25.8)














indication for shunt placement
IVH 631 (8.9)
myelomeningocele 992 (14.0)











other congenital/genetic 505 (7.1)
malignancy 317 (4.5)
LOS prior to initial shunt placement
0-2 days 2410(34.1)
3-7 days 1849 (26.1)
8-14 days 1103(15.6)








Characteristic No. of Patients (%)
























t  Race/ethnicity data are missing in 347 children (306 without infec­
tion, 41 with infection).
$ Insurance data are missing in 1 child.
All statistical analyses were performed using com­
mercially available software (SAS version 9.1, SAS Insti­
tute, Inc.), and probability values < 0.05 were considered 
statistically significant.
Results
For the time period we specified, the PHIS database 
contained information obtained in 7071 children with un­
complicated initial CSF shunt placements and 24 months 
of follow-up (Fig. 1). During the follow-up period, this 
group had 825 first CSF shunt infections and a total of 
4434 subsequent CSF shunt revision procedures. The 
overall unadjusted 24-month CSF shunt infection rates 
were 11.7% per patient (825 of 7071 patients) and 7.2% 
per procedure (825 of 11,505 procedures). Description 
of the patient, hospital, and surgeon factors for the study 
population are shown in Table 1.
The unadjusted 24-month infection rates aggregated 
by hospital ranged from 4.1 to 20.5% per patient. (Fig. 2) 
The unadjusted 24-month infection rates aggregated by 
hospital ranged from 2.5 to 12.3% per procedure (data 
not shown).
Patient factors that were significantly associated with 
infection in bivariate analysis in this cohort included young 
age, African-American race/ethnicity, public insurance,
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Fig. 2. Bar graph showing variation in unadjusted 24-month cumulative infection incidence rates per patient, aggregated by 
hospital in 6979 patients. Error bars indicate SE.
etiology of IVH, respiratory CCC, and subsequent revision 
procedures (Table 2). Female sex and Asian race/ethnicity 
were associated with infection, but not as strongly. Malig­
nant lesions, including CNS tumor and malignancy CCC, 
and trauma etiology were protective. In addition, lower 
hospital and surgeon volumes were associated with CSF 
shunt infection.
When infection rates for each hospital were adjusted 
for significant factors, the range of 24-month infection 
rates decreased to 8.8-12.8% per patient (Fig. 3) and 1.4­
5.3% per procedure (data not shown).
Factors that remained significantly associated with in­
fection in multivariable analysis included young age, Af­
rican-American race/ethnicity, Asian race/ethnicity, public 
insurance, subsequent revision procedure(s), and to a lesser 
degree female sex (Table 3). Hospital and surgeon factors 
tested did not remain significantly associated with infec­
tion. Interactions between age and other covariates and sur­
gical volume and other covariates were tested,4 and none 
were significant.
Discussion
In this large, multicenter longitudinal cohort of chil­
dren undergoing uncomplicated initial CSF shunt place­
ment, > 11% of children were readmitted within 24 months 
for subsequent CSF shunt infection. About 35% of these 
children were readmitted within 24 months for subsequent 
CSF shunt revisions, generating an overall infection rate 
per procedure of 7%. Infection rates aggregated by hos-
2.5-12.3% per procedure.
Patient factors that were significantly associated with 
infection in this cohort included young age, female sex, Af­
rican-American race/ethnicity, Asian race/ethnicity, public 
insurance, and subsequent revision procedures. Lower hos­
pital volumes and particularly lower surgeon volumes were 
associated with CSF shunt infections in bivariate but not
When infection rates for each hospital were adjusted
for significant factors, the range of 24-month infection 
rates decreased to 8.8-12.8% per patient and 1.4-5.3% per 
procedure. Some, but not all, of the variation in CSF shunt 
infection rates between hospitals was attributable to those 
factors.
Infection Rates
Published rates of CSF shunt infection vary widely
design including rate numerators and denominators,141920 
definition of shunt infection,533 42 45 and duration of sur­
veillance.1743 In this study we were able to overcome 2 of 
these limitations, rate numerators and denominators and 
duration of surveillance, by applying a definition of CSF 
shunt infection (the discharge diagnosis code of CSF shunt 
infection confirmed by chart review at a single hospital) 
in a database containing administrative and clinical data 
from 41 children’s hospitals. Although our study popula­
tion is so uniquely constructed that there is no relevant pri­
or literature to cite, our findings are not inconsistent with 
prior work given our relatively uncomplicated study pa­
tient population. This study demonstrated an overall CSF 
shunt infection rate per patient of 11.7% with a range of 
4.1-20.5%. Although few studies report infection rates per 
patient, earlier reports of such infection rates range from 
6.5 to 23.5%.3-5JOJ-,J8Z,'4;: This study also demonstrated an 
overall CSF shunt infection rate per procedure of 7.2% 
with a range of 2.5-12.3%. The majority of studies report 
CSF shunt infection rates per procedure, and these rates 
are generally 8-10% in recent series but range from 0 to 
35%_y,22,2-,2y,3<l,.w34,36,38-4<l,45 This cohort’s 24-month shunt 
survival rate of 65% is higher than previously reported,4 23 
and likely reflects the fact that initial CSF shunts were un­
complicated and did not include children with surgical in­
terventions such as reservoirs prior to shunt placement.
Factors Associated With CSF Shunt Infection
We were able to test the association of several patient 
factors with CSF shunt infection. As have authors of ear­
lier studies, we found an association between CSF shunt
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TABLE 2: Comparison of population with and without infection at 24 months
Characteristic
No. of Patients (%)
W/o Infection (6246 patients) W/ Infection (825 patients)
age (p < 0.001)
<30 days 1724 (27.6) 285 (34.5)
1-6 mos 1510 (24.2) 226 (27.4)
6 -48  mos 1624 (26.0) 199 (24.1)
>48 mos 1388 (22.2) 115(13.9)
sex (p = 0.039)
male 3545 (56.8) 437 (53.0)
female 2701 (43.2) 388 (47.0)
*
non-Latino white 3292 (55.4) 396 (50.5)
non-Latino black 1015(17.1) 198 (25.3)
Latino 964(16.2) 103(13.1)
Asian 82(1.4) 17 (2.2)
other 587 (9.9) 70 (8.9)
t
public 2811 (45.0) 423 (51.3)
private 2071 (33.2) 242 (29.3)
other 1363 (21.8) 160(19.4)
indication for shunt placement
IVH (p = 0.03) 541 (8.7) 90 (10.9)
myelomeningocele (p = 0.12) 891 (14.3) 101 (12.1)
CNS tumor (p = 0.005) 850 (13.6) 83(10.1)
meningitis (p = 0.18) 142 (2.3) 25 (3.0)
trauma (p = 0.03) 179 (2.9) 13(1.6)
presence of CCC(s)
neuromuscular (p = 0.39) 460 (7.4) 54 (6.5)
cardiovascular (p = 0.65) 649 (10.4) 90 (10.9)
respiratory (p = 0.01) 390 (6.2) 70 (8.5)
renal (p = 0.36) 135 (2.2) 22 (2.7)
gastrointestinal (p = 0.87) 33 (0.5) 4 (0.5)
hematological (p = 0.92) 32 (0.5) 4 (0.5)
metabolic {p = 0.12) 44 (0.7) 2(0.2)
other congenital/genetic (p = 0.77) 444 (7.1) 61 (7.4)
malignancy (p = 0.05) 291 (4.7) 26 (3.2)
LOS prior to initial shunt placement (p = 0.54)
0 -2  days 2147 (34.4) 263 (31.9)
3-7  days 1622 (26.0) 227 (27.5)
8-14 days 972 (15.6) 131 (15.9)
>15 days 1505 (24.1) 204 (24.7)
distal shunt location (p = 0.41)
ventriculoperitoneal 6135 (98.2) 807 (97.8)
other 111 (1.8) 18 (2.2)
case mix index at initial CSF shunt placement (p = 0.26)
low 4301 (68.9) 591 (71.6)
moderate 1031 (16.5) 122(14.8)
high 914(14.6) 112(13.6)
(continued)
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TABLE 2: Comparison of population with and without Infection at 24 months (continued)
No. of Patients (%)
Characteristic W/o Infection (6246 patients) W/ Infection (825 patients)
revision admissions following initial CSF shunt placement (p < 0.001)
none 4166 (66.7) 351 (42.5)
1 1318(21.1) 198 (24.0)
>2 762 (12.2) 276 (33.5)
hospital volume (initial CSF shunt placements/yr) (p = 0.005)
1-20 314 (5.0) 46 (5.6)
21-40 1763 (28.2) 219(26.5)
41-60 2747 (44.0) 409 (49.6)
>61 1422 (22.8) 151 (18.3)
surgeon volume (initial CSF shunt placements/yr) (p = 0.03)
<10 1786 (28.6) 256(31.0)
11-20 2244 (35.9) 320 (38.8)
21-30 1236 (19.8) 143(17.3)
>30 980 (15.7) 106 (12.8)
season of initial CSF shunt placement (p = 0.66)
spring 1697 (27.2) 231 (28.0)
summer 1675 (26.8) 207 (25.1)
fall 1390 (22.3) 180 (21.8)
winter 1484 (23.8) 207 (25.1)
* Race/ethnicity data are missing in 347 children (306 without infection, 41 with infection), 
t  Insurance data are missing in 1 child.
8 , l3 ,2 l , .W J 5 J 7 4 2 asinfection and younger chronological age,: 
well as revision procedures.2 21 3042 Like previous work, 
v found no association between CSF shunt infecsour s _
tion and length of stay prior to shunt placement.27
In contrast to earlier studies,11 26273037 ours found a 
small but statistically significant association between CSF 
shunt infection and female sex, both African-American and 
Asian race/ethnicity, and public insurance. These findings 
were seen in both bivariate and multivariable analyses. The 
effect sizes for female sex and public insurance were fairly 
small. The associations of African-American and Asian
race/ethnicity with CSF shunt infection appear more sig­
nificant and warrant further study. We may have had these 
findings because our population was substantially larger 
than that of most previous CSF shunt infection studies.
We were able to examine the association between CSF 
shunt infection and several different indications for shunt 
placement including IVH, myelomeningocele, CNS tumor, 
and meningitis. Because we limited our study population 
to uncomplicated initial CSF shunt placements, we had a 
very small proportion of children with IVH (8.9%) and few 
with trauma (2.7%). Of these indications, our study found
Fig. 3 . Bar graph of the variation in adjusted 24-month cumulative infection incidence rates per patient, aggregated by hospital 
in 6979 patients. Rates were adjusted for hospital, sex, race/ethnicity, payer, and number of revisions. Error bars indicate SE.
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TABLE 3: Odds of first Infection* TABLE 3: Odds of first Infection* (continued)
Characteristic
OR (95% Cl) 
Unadjusted Adjusted
age
<30 days 2.0(1.6-2.5) 1.6(12-2.1)
1-6 mos 1.8(1.4-2.3) 1.5(11-2.0)
6 -48  mos 1.5 (1.2-1.9) 1.5(11-19)
>48 mos referent referent
sex
male referent referent
female 1.2 (1.0-1.3) 1.2(10-14)
race/ethnicity
non-Latino white referent referent
non-Latino black 1.6 (1.3-2.0) 1.5 (12-19)
Latino 0.9 (0.7-1.1) 0.9(0.7-11)
Asian 1.7(1.0-2.9) 1.7(10-3.0)
other 1.0 (0.8-1.3) 0.9(0.7-12)
payer
public 1.3 (1.1—1.5) 1.3(11-16)
private referent referent
other 1.0 (0.8-1.2) 1.0(0.8-13)
indication for shunt placement
IVH 1.3 (1.0-1.6) 0.9(0.7-12)
myelomeningocele 0.8 (0.7-1.0)
CNS tumor 0.7 (0.6-0.9) 1.1 (0.8-15)
meningitis 1.3 (0.9-2.1)
trauma 0.5 (0.3-1.0) 0.7(0.4-13)









other congenital/genetic 1.0 (0.8-1.4)
malignancy 0.7 (0.4-1.0) 0.8(0.5-12)
LOS prior to initial shunt placement
0 -2  days referent
3-7  days 1.1 (0.9-1.4)
8-14 days 1.1 (0.9-1.4)















>2 4.3 (3.6-5.1) 4.2 (3.5-5.1)
hospital volume (initial CSF shunt place- 
ments/yr)
1-20 1.4(10-2.0) 1.3 (0.9-19)
21-40 1.2(0.9-15) 1.0(0.8-13)
41-60 1.4(12-17) 1.2 (10-15)
>61 referent referent
surgeon volume (initial CSF shunt place- 
ments/yr)
<10 1.3(10-17) 1.2(0.9-15)
11-20 1.3(10-17) 1.1 (0.8-14)
21-30 1.1 (0.8-14) 0.9 (0.7-12)
>30 referent referent





* Values shaded in gray are statistically significant (p < 0.05). Only 
covariates with p < 0.10 were included in the multivariate model.
an association of IVH with infection,11 3642 and negative as­
sociations with CNS tumor and trauma. These associations 
did not remain significant in multivariable analysis.
By using CCCs, we were able to examine comorbidities 
more extensively than has been done in earlier studies.12 2737 
We found an association between respiratory CCC and an 
intriguing protective effect of malignancy CCC in the bi- 
variate analysis. Neither association remained significant 
in the multivariable analysis.
We were also able to test several hospital and surgeon 
factors. As in earlier work,9 we did find an association be­
tween CSF shunt infection and both hospital and surgeon 
volume. These associations did not persist in the multi­
variable analysis. We were unable to test either individual 
surgeon59 1032 45 or his/her experience level.910 Unlike ear­
lier work,25 however, we did not find an association be­
tween CSF shunt infection and time of year.
(continued)
Study Limitations
The major limitation of this study is that of the eco­
logical fallacy:31 that is, we cannot infer an individual pa­
tient’s risk of infection based on the treating hospital’s 
infection rate. In addition, data available from adminis­
trative datasets such as PHIS is limited. Although we can 
use some patient, hospital, and surgeon factors as covari­
ates, many factors of clinical interest (such as gestational 
age, postconceptional age, birth weight, weight at surgery,
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individual surgeon, surgeon experience, and modifiable 
surgical decisions such as the use of prophylactic antibi­
otics) are not available. Some of the available covariates 
(such as indication for initial shunt and CCCs) are prob­
lematic given their dependence on ICD-9-CM diagnosis 
codes, which are less reliable than procedure codes.28 For 
example, we cannot assess the association of aqueductal 
stenosis with CSF shunt infection. The restriction of our 
study population to only uncomplicated initial CSF shunt 
placements (due to ICD-9-CM coding) resulted in a rela­
tively low-risk population, but allowed us to standardize 
comparisons across hospitals. Future prospective multi­
center studies of CSF shunt infections will permit us to 
improve data collection for these and other risk factors, 
permitting us to overcome the limitations associated with 
the retrospective use of administrative data when com­
paring infection rates between centers. The study design 
assumes a patient is seen for follow-up at the same hospi­
tal where his shunt was placed, which may not be true; we 
assumed equal rates of drop-out across hospitals.
Infection Rates Following Adjustment
The new and most striking finding of this study was the 
demonstration of the degree to which patient, hospital, and 
surgeon factors contributed to the wide variation in CSF 
shunt infection rates across hospitals. Although unadjusted 
infection rates per patient for each hospital ranged from 4.1 
to 20.5%, adjustment decreased the range of infection rates 
to 8.8-12.8%. Unadjusted infection rates per procedure for 
each hospital ranged from 2.5 to 12.3%, and adjusted rates 
ranged from 1.4 to 5.3% per procedure. Some, but not all, 
of the variation in CSF shunt infection rates between hos­
pitals was attributable to differences in these patient, hos­
pital, and surgeon factors between hospitals.
Although we were able to use some patient, hospital, 
and surgeon factors as covariates when comparing be­
tween centers, there are many factors of clinical interest 
that we were either not able to assess or not able to as­
sess completely. These included factors previously con­
sidered in association with infection (such as gestational 
age, postconceptional age, birth weight, weight at surgery, 
indication for initial CSF shunt placement, comorbidities, 
individual hospital, individual surgeon, and surgeon ex­
perience); modifiable surgical decisions such as double 
gloving and the use of prophylactic antibiotics; and theo­
retical risk factors such as patient immune function and/ 
or bacterial load at the time of initial shunt placement. To 
allow for accurate comparisons between centers, future 
studies (such as benchmarking and/or future prospective 
multicenter studies of CSF shunt infection) must improve 
data collection to allow for consideration of these and 
other potential risk factors.
Conclusions
In the present study, we examined infection rates in a 
large longitudinal cohort across several US hospitals us­
ing a standard CSF shunt infection rate numerator and 
denominator, definition, and duration of surveillance. An 
infection develops within 24 months in > 11% of children 
(4.1-20.5%) who undergo an uncomplicated initial CSF
shunt placement. Patient, hospital, and surgeon factors 
such as patient age, race/ethnicity, insurance, and number 
of shunt revisions, hospital volume, and surgeon volume 
contribute somewhat to the wide variation in CSF shunt 
infection rates across hospitals. Additional factors may 
contribute to variation in CSF shunt infection rates be­
tween centers, but further study is needed. Future work 
comparing CSF shunt infection between centers, such as 
benchmarking and future prospective multicenter studies, 
must take into account these factors.
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